Navigation Links
Conference on cell therapy includes new session on stem cells for non-cardiac organ injury
Date:1/5/2009

WHAT:

The Fifth International Conference on Cell Therapy for Cardiovascular Disease (IC3D) will include a new session on stem cells for non-cardiac organ injury. The session will include new data on stem cells for islet disease and diabetes, bone marrow cells for stroke patients, and treating Parkinson's disease with bone marrow cells.

Highlights from other sessions include the first human data using special bone marrow and adipose cells for heart attack patients and a discussion of the rapid advances in tissue engineering and how surgeons should prepare for this next stage of stem cell therapy.

WHY:

IC3D, one of the largest conferences of its kind with more than 60 internationally recognized faculty members, is a three-day comprehensive program dedicated to the evolving field of cell-based therapies for cardiac repair and regeneration. The theme of this year's meeting is "Cellular and Molecular Building Blocks: Strategies for Cardiovascular Reconstruction in 2009."

The conference encompasses all aspects of cell-based therapeutic approaches to cardiovascular diseases. Research presented at IC3D will touch upon clinical studies of stem cell repair of the heart, brain and peripheral arteries, new sources of adult stem cells and the status of embryonic stem cell research. Each day of the conference will focus on the following diseases and the future role of cell-based therapies.

PROGRAM SPECIFICS:

New sessions for 2009 will include:

  • Major advances in treating peripheral vascular disease
  • Combined cell and tissue regenerative methods
  • Changing the potential of stem cells: Why should we try? How do we do it?
  • New paradigms for the surgeon? How soon will engineered tissue be in the clinic?
  • Discoveries beyond the heart, including the brain and other organs
  • Expanded sessions on Industry Innovations in 2009

The full agenda can be found at: http://www.crf.org/Cell_Therapy/agenda.html.

WHO:

Warren Sherman, M.D., Conference Director, is Director of Cardiac Cell-Based Endovascular Therapies at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital and Columbia University Medical Center. Dr. Sherman is a renowned clinical investigator in the field of myocardial regeneration who pioneered a technique for injecting stem cells into the heart. In Rotterdam in May 2001, he performed the first catheter-based injection of stem cells into the heart of a patient with congestive heart failure due to a previous heart attack. At Columbia University Medical Center, researchers led by Dr. Sherman are using the patient's own myoblasts -- progenitor cells found in muscle -- to repair and replace injured cardiac tissue in a process called myogenesis. Dr. Sherman collaborates in studies to improve the outcomes of cell implantation with colleagues at Columbia University Medical Center, all of whom will be presenting their research at the conference.

WHEN:

January 13 16, 2009

WHERE:

The New York Academy of Medicine
New York, NY


'/>"/>

Contact: Judy Romero
jromero@crf.org
212-851-9311
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 a.m. (ET)
2. Alexion to Present at the 27th Annual JP Morgan Healthcare Conference
3. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
4. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009
5. WellPoint to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 28, 2009
6. 40 Days for Life Leader to Speak at Personhood Conference
7. Delcath Systems to Host Quarterly Update Conference Call
8. Medco CEO to Present at the 2009 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference
9. Spending Too Much on Healthcare? This Employer-Designed Conference Will Inspire!
10. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14
11. Abaxis, Inc. to Present at Needham & Companys Eleventh Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... ... 28, 2017 , ... Bill Howe started his sewer and drain company in ... Howe joined the team, the Bill Howe brand was born and they began cultivating ... giving back to the San Diego community in which they worked, lived and were ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a leading ... Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, a ... of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and Vitamin ...
(Date:4/27/2017)... ... April 27, 2017 , ... Today, Jefferson Health in Philadelphia ... announced an agreement to create the Jane and Leonard Korman Respiratory Institute in ... Leonard Korman Family Foundation. The collaboration leverages the strengths of each organization and ...
(Date:4/27/2017)... ... 27, 2017 , ... Last night, Christine Collins of New ... for her extraordinary compassion and lifelong dedication to serve others. Since 1997, Home ... the prestigious award each year – identifying a CAREGiver who has exemplified exceptional ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology: